The COVID-19 pandemic has profound adverse effects on the population on dialysis.
Patients requiring dialysis are at an increased risk of SARS-CoV-2 infection and mortality …

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the causative agent of
coronavirus disease 2019 (COVID-19), has infected over 600 million individuals and caused …

Importance Adults receiving dialysis treatment have a higher likelihood of death when
infected with SARS-CoV-2 than adults not receiving dialysis treatment. To date, the immune …

Rationale and objective COVID-19 vaccination is the most effective way to prevent COVID-
19. For chronic kidney disease patients on long-term dialysis, there is a lack of evidence on …

We read with interest a recent article reported by Ao et al. 1 The authors reported a meta-
analysis describing the outcomes of hemodialysis patients infected with COVID-19 after …

Patients with end-stage renal disease (ESRD) receiving hemodialysis (HD) were found to
have a decreased immune response following mRNA COVID-19 immunization. ChAdOx1 …

Abstract Background and Aim Dialysis patients are a high-risk population and have a
reduced immune response to vaccination against SARS-CoV-2. The aim of this study was to …

Background In peritoneal dialysis (PD) patients, information on the immunogenicity and
tolerability of SARS‐CoV‐2 vaccination is still scarce. We compared the immunogenicity and …

Abstract Background and Aims Vaccine response is a concern in hemodialysis patients.
Given that hemodialysis patients were not included in clinical trials, we aimed to synthesize …

Abstract The coronavirus disease 2019 (COVID‑19) vaccination is the most effective way to
prevent COVID‑19. However, for chronic kidney disease patients on long‑term dialysis, there …